Skip to content

Wako Autokit Albumin

by Wako Chemicals USA, Inc. 510(k)

Active United States

510(k) K880313

Overview

The Wako Autokit Albumin is a Bromcresol Green Dye-Binding Albumin diagnostic reagent, classified under Clinical Chemistry. It is designed for the quantitative measurement of serum albumin levels using a colorimetric assay, where bromcresol green dye binds to albumin, enabling spectrophotometric detection of its concentration in patient samples.

This device is supplied as a non-sterile, single-use reagent kit for in vitro diagnostic use in clinical chemistry laboratories. It is intended for use with automated chemistry analyzers and requires no special storage conditions beyond refrigeration (2–8°C) as specified in the instructions. The product holds FDA 510(k) clearance (K880313) under the Traditional review pathway, with a classification as a Class II device (CIX). No MRI safety or reusable components are indicated.

AI-generated from registry data, 19 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK880313 Date24 Mar 1988ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 22 Oct 2026)

Specification

510(k)

Full name
Wako(Tm) Autokit Albumin
510(k) Number
FDA Product Code
CIX
Device Class
Class II
Regulation
21 CFR Part 862.1035
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Wako Chemicals USA, Inc.

See all devices from Wako Chemicals USA, Inc. →

Questions

  • What clinical chemistry measurement does the Wako Autokit Albumin specifically enable, and how does it work?

    The Wako Autokit Albumin is designed for the quantitative measurement of serum albumin levels using a colorimetric assay. It employs bromcresol green dye, which binds to albumin in patient samples. The resulting complex is then detected spectrophotometrically, allowing for precise concentration determination. This method is commonly used in clinical chemistry laboratories to assess liver function, nutritional status, and overall protein balance in patients.

  • Is this reagent kit intended for use with specific types of laboratory equipment, and what storage conditions are required?

    Yes, the Wako Autokit Albumin is specifically intended for use with automated chemistry analyzers in clinical chemistry laboratories. It is supplied as a single-use, non-sterile reagent kit. Storage is straightforward—simply refrigerate the kit between 2°C and 8°C, following the instructions provided. No additional specialized storage conditions are required.

  • How is the Wako Autokit Albumin regulated in the U.S., and what classification does it hold?

    The Wako Autokit Albumin holds FDA 510(k) clearance under the Traditional review pathway, with a classification as a Class II device (CIX). This designation reflects its role as a diagnostic reagent for in vitro use in clinical chemistry, ensuring it meets regulatory standards for safety and performance without requiring the stringent controls of a Class III device.

  • Can this reagent be reused, and what are the implications of its single-use nature?

    No, the Wako Autokit Albumin is explicitly designed for single-use only. This ensures accuracy and reliability in measurements, as repeated use could introduce variability or contamination. The single-use nature aligns with best practices in clinical chemistry to maintain precision and patient safety, particularly in automated systems where consistency is critical.

  • What are the key details about the manufacturer and regulatory submission history for this product?

    The Wako Autokit Albumin is manufactured by Wako Chemicals USA, Inc., based in Dallas, TX. The product was submitted for FDA clearance in 1988 under the advisory committee for Clinical Chemistry (CH) and holds the clearance number K880313. The submission was determined to be substantially equivalent (SESE) to a predicate device, reflecting its classification as a well-established diagnostic reagent in the field of clinical chemistry.